Articles tagged with: AGITG

Surgical Workshop

Sunday, 24 January 2016 Posted in News, 2016

Surgical Workshop

In 2015 Avner’s Foundation funded a surgical workshop that brought together medical experts from around Australia, including surgeons, medical oncologists, radiologists, pathologists and gastroenterologists.

Trial Update

Monday, 04 June 2012 Posted in News, 2012

In exciting developments, three patients have now joined the PAN 1 study. The PAN 1 study aim is to prospectively evaluate hENT1 as a predictive biomarker of benefit from gemcitabine treatment in advanced Pancreatic Cancer. In lay English, this means researchers at the AGITG will test whether hENT1 can show whether an individual patient with advanced Pancreatic Cancer will get benefit from the standard Pancreatic Cancer chemotherapy drug Gemcitabine or not.